Monoclonal antibody infusion is shown to significantly reduce the risk of hospitalization or death in people age 65 or older, and those with certain chronic medical conditions, such as diabetes, heart disease, or obesity. Children ages 12 and over who have serious medical conditions may also benefit from the treatment.
“Nationally, individuals with certain risk factors who develop COVID-19 have a 15 percent chance of being hospitalized,” said Brian J. Young, MD, of Penn Medicine Lancaster General Health Physicians Family Medicine Twin Rose. “The infusion treatment reduces that risk to less than 5 percent.”